Wells Fargo upgraded Ryan Specialty (RYAN) to Overweight from Equal Weight with an unchanged price target of $60. The recent pullback in the shares puts Ryan’s valuation in-line with the rest of the brokerage group, the analyst tells investors in a research note. The firm believes the company’s organic growth and margins will continue to outpace a sector, warranting a premium valuation relative to peers.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Wolfe Research launches coverage with positive view on Life Insurance names
- Ryan Specialty assumed with Outperform from Peer Perform at Wolfe Research
- Ryan Specialty Group Appoints Michael Bungert to Board
- Ryan Specialty price target lowered to $68 from $71 at Morgan Stanley
- C3 AI downgraded, Capri upgraded: Wall Street’s top analyst calls